Pavel Andreevich Chizhkov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pavel Andreevich Chizhkov has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Svetlana Nikolaevna Lagutina
Voronezh State Medical University named after N.N. Burdenko
7 shared publications - Mikhail Yu. Syromyatnikov
Voronezh State University of Engineering Technologies
4 shared publications - Elena Yuryevna Esina
Voronezh State Medical University
3 shared publications - Inna Burakova
Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia
3 shared publications - Irina Sergeevna Dobrynina
Surgut State University, Surgut, Russia
3 shared publications - Mariya V. Gryaznova
Laboratory of Metagenomics and Food Biotechnology, Voronezh State University of Engineering Technologies, 394036 Voronezh, Russia
3 shared publications
Latest Publications
- Open Access
- 21 June 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 96-104
Genetic factors predisposing to the development of gastroesophageal reflux disease (literature review)
Gastroesophageal reflux disease (GERD) is a chronic, multifactorial disorder characterized by dysfunction of the gastroesophageal junction and impaired esophageal clearance, leading to pathological reflux. Objective: To analyze the literature on the role of genetic factors in the development of GERD and its complications. It was found that the development and progression of GERD is associated with polymorphisms in key genes. These include genes encoding proinflammatory cytokines, signaling molecules, epidermal growth factor, and the FOXF1 and MHC markers. Damage to mtDNA plays a significant role, leading to activation of oxidative stress and cellular dysfunction. Genetic factors create an individual predisposition, determining the response of the esophageal mucosa to chronic reflux and the risk of malignant transformation. Genetic factors (genetic polymorphisms, mtDNA damage) can play a key role in the severity of clinical manifestations of GERD and the development of complicated forms of the disease.
- 21 June 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 96-104
Open AccessGenetic factors predisposing to the development of gastroesophageal reflux disease (literature review)
Gastroesophageal reflux disease (GERD) is a chronic, multifactorial disorder characterized by dysfunction of the gastroesophageal junction and impaired esophageal clearance, leading to pathological reflux. Objective: To analyze the literature on the role of genetic factors in the development of GERD and its complications. It was found that the development and progression of GERD is associated with polymorphisms in key genes. These include genes encoding proinflammatory cytokines, signaling molecules, epidermal growth factor, and the FOXF1 and MHC markers. Damage to mtDNA plays a significant role, leading to activation of oxidative stress and cellular dysfunction. Genetic factors create an individual predisposition, determining the response of the esophageal mucosa to chronic reflux and the risk of malignant transformation. Genetic factors (genetic polymorphisms, mtDNA damage) can play a key role in the severity of clinical manifestations of GERD and the development of complicated forms of the disease.
- 30 December 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 30-34
Features of the oral microbiome composition in men with gastroesophageal reflux disease with esophagitis
This article presents a study conducted to investigate changes in the oral microbiome composition in patients with GERD and esophagitis and to identify potential microbiological predictors of complications. In total 106 patients with a previously verified diagnosis participated. Quantitative real-time PCR was the primary method for assessing the oral microbiome composition. A significant decrease in all phyla of the studied bacteria was found in patients with GERD compared to the control group. The bacterial phyla studied can be used as a predictor of GERD development only in healthy individuals to determine the likelihood of inflammation in healthy mucous membranes, which requires further exploration and study of new biomarkers. The aim of the study: to determine the composition of the oral microbiome in patients with GERD of varying severity and to identify possible microbiological predictors of the development of GERD complications. A total of 106 men aged 35.5±3.4 years were examined, 27 of whom were somatically healthy and 79 of whom were diagnosed with GERD with esophagitis (according to the Los Angeles classification: 26 people with GERD-A, 25 people with GERD-B, and 28 people with GERD-C), who were in remission at the time of the examination. A comparison was made of the state of the oral microbiome in healthy men and men with gastroesophageal reflux disease. In patients with GERD-A and GERD-B, reliable differences were found only in relation to Bacteroidetes bacteria - a decrease in their level was noted, Firmicutes - an increase in their content in the oral cavity was recorded depending on the severity of GERD, as well as the phylum Tenericutes - an increase in the number of bacteria was revealed at severe stages of GERD. It is worth noting that in patients GERD-C recorded a reliable decrease in all phyla of the studied bacteria. The bacterial phyla we studied can be used as a predictor of the development of gastroesophageal reflux disease only in healthy individuals, in order to determine the likelihood of GERD with esophagitis.
- 30 December 2025
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 4,p. 30-34
Features of the oral microbiome composition in men with gastroesophageal reflux disease with esophagitis
This article presents a study conducted to investigate changes in the oral microbiome composition in patients with GERD and esophagitis and to identify potential microbiological predictors of complications. In total 106 patients with a previously verified diagnosis participated. Quantitative real-time PCR was the primary method for assessing the oral microbiome composition. A significant decrease in all phyla of the studied bacteria was found in patients with GERD compared to the control group. The bacterial phyla studied can be used as a predictor of GERD development only in healthy individuals to determine the likelihood of inflammation in healthy mucous membranes, which requires further exploration and study of new biomarkers. The aim of the study: to determine the composition of the oral microbiome in patients with GERD of varying severity and to identify possible microbiological predictors of the development of GERD complications. A total of 106 men aged 35.5±3.4 years were examined, 27 of whom were somatically healthy and 79 of whom were diagnosed with GERD with esophagitis (according to the Los Angeles classification: 26 people with GERD-A, 25 people with GERD-B, and 28 people with GERD-C), who were in remission at the time of the examination. A comparison was made of the state of the oral microbiome in healthy men and men with gastroesophageal reflux disease. In patients with GERD-A and GERD-B, reliable differences were found only in relation to Bacteroidetes bacteria - a decrease in their level was noted, Firmicutes - an increase in their content in the oral cavity was recorded depending on the severity of GERD, as well as the phylum Tenericutes - an increase in the number of bacteria was revealed at severe stages of GERD. It is worth noting that in patients GERD-C recorded a reliable decrease in all phyla of the studied bacteria. The bacterial phyla we studied can be used as a predictor of the development of gastroesophageal reflux disease only in healthy individuals, in order to determine the likelihood of GERD with esophagitis.
- 31 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (10) , 99-102
The importance of screening preventive examination at the outpatient stage
Malignant neoplasms (MNs) have always been and remain the most complicated social and medical issues. At present, a number of screening tests, the latest methods of diagnosis and early detection of MNs have been proposed, but the incidence is increasing despite all the measures applied. Objective. To draw attention to the importance of early detection of abnormalities in annual medical examinations, screening tests and the role of coordinated work of all specialists (district general physician, radiologist, oncologists working in polyclinic and oncological dispensary). Case report. At the annual medical examination of patient P., 28 years old, a rounded formation of the upper lobe of the right lung with suspicion of atypical inflammation has been revealed on a fluoroscopic image of the thoracic organs (TOs). The TOs computed tomography (TOs CT) has revealed a neoplasm with an uneven contour sized 13×10 mm. The patient was referred to a pulmonologist; a preliminary diagnosis has been established: Benign neoplasm of the bronchus and lung. He was referred to the oncologist in the oncological dispensary. During additional examination and contrast-enhanced CT, accumulation of 10—12% of contrast has been noted in the neoplastic focus, that did not allow to completely exclude the malignant nature of the pathological process. Nevertheless, performance of a biopsy with subsequent histological study was complicated due to the localization of the focus. To confirm the diagnosis and exclude the endophytic growth of the formation, a bronchoscopy was done. It has been concluded that the neoplasm corresponds to the locus of fibrosis with atypical inflammation. Treatment was prescribed. A year after, when performing the TOs CT, positive dynamics was noted, that confirmed the fibrous structure of formation. Conclusion. Early detection of oncological diseases by primary care physicians remains a key objective of practical healthcare, since reduction of mortality rate due to oncopathology can be achieved only with timely detection of the disease.
- 31 October 2025
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 28 (10) , 99-102
The importance of screening preventive examination at the outpatient stage
Malignant neoplasms (MNs) have always been and remain the most complicated social and medical issues. At present, a number of screening tests, the latest methods of diagnosis and early detection of MNs have been proposed, but the incidence is increasing despite all the measures applied. Objective. To draw attention to the importance of early detection of abnormalities in annual medical examinations, screening tests and the role of coordinated work of all specialists (district general physician, radiologist, oncologists working in polyclinic and oncological dispensary). Case report. At the annual medical examination of patient P., 28 years old, a rounded formation of the upper lobe of the right lung with suspicion of atypical inflammation has been revealed on a fluoroscopic image of the thoracic organs (TOs). The TOs computed tomography (TOs CT) has revealed a neoplasm with an uneven contour sized 13×10 mm. The patient was referred to a pulmonologist; a preliminary diagnosis has been established: Benign neoplasm of the bronchus and lung. He was referred to the oncologist in the oncological dispensary. During additional examination and contrast-enhanced CT, accumulation of 10—12% of contrast has been noted in the neoplastic focus, that did not allow to completely exclude the malignant nature of the pathological process. Nevertheless, performance of a biopsy with subsequent histological study was complicated due to the localization of the focus. To confirm the diagnosis and exclude the endophytic growth of the formation, a bronchoscopy was done. It has been concluded that the neoplasm corresponds to the locus of fibrosis with atypical inflammation. Treatment was prescribed. A year after, when performing the TOs CT, positive dynamics was noted, that confirmed the fibrous structure of formation. Conclusion. Early detection of oncological diseases by primary care physicians remains a key objective of practical healthcare, since reduction of mortality rate due to oncopathology can be achieved only with timely detection of the disease.
- Open Access
- 12 July 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (7) , 1414
Fecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel Syndrome
Background: Irritable bowel syndrome (IBS) is a common condition that affects the lifestyle of patients. It is associated with significant changes in the composition of the gut microbiome, but the underlying microbial mechanisms remain to be fully understood. We study the fecal microbiome of patients with constipation-predominant IBS (IBS-C) and mixed-type IBS (IBS-M). Methods: We sequenced the V3 region of the 16S rRNA on the Ion Torrent PGM sequencing platform to study the microbiome. Results: In the patients with IBS-C and IBS-M, an increase in alpha diversity was found, compared to the healthy group, and differences in beta diversity were also noted. At the phylum level, both IBS subtypes showed an increase in the Firmicutes/Bacteroidetes ratio, as well as an increase in the abundance of Actinobacteria and Verrucomicrobiota. Changes in some types of bacteria were characteristic of only one of the IBS subtypes, while no statistically significant differences in the composition of the microbiome were detected between IBS-C and IBS-M. Conclusions: This study was the first to demonstrate the association of Turicibacter sanguinis, Mitsuokella jalaludinii, Erysipelotrichaceae UCG-003, Senegalimassilia anaerobia, Corynebacterium jeikeium, Bacteroides faecichinchillae, Leuconostoc carnosum, and Parabacteroides merdae with IBS subtypes.
- 12 July 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (7) , 1414
Open AccessFecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel Syndrome
Background: Irritable bowel syndrome (IBS) is a common condition that affects the lifestyle of patients. It is associated with significant changes in the composition of the gut microbiome, but the underlying microbial mechanisms remain to be fully understood. We study the fecal microbiome of patients with constipation-predominant IBS (IBS-C) and mixed-type IBS (IBS-M). Methods: We sequenced the V3 region of the 16S rRNA on the Ion Torrent PGM sequencing platform to study the microbiome. Results: In the patients with IBS-C and IBS-M, an increase in alpha diversity was found, compared to the healthy group, and differences in beta diversity were also noted. At the phylum level, both IBS subtypes showed an increase in the Firmicutes/Bacteroidetes ratio, as well as an increase in the abundance of Actinobacteria and Verrucomicrobiota. Changes in some types of bacteria were characteristic of only one of the IBS subtypes, while no statistically significant differences in the composition of the microbiome were detected between IBS-C and IBS-M. Conclusions: This study was the first to demonstrate the association of Turicibacter sanguinis, Mitsuokella jalaludinii, Erysipelotrichaceae UCG-003, Senegalimassilia anaerobia, Corynebacterium jeikeium, Bacteroides faecichinchillae, Leuconostoc carnosum, and Parabacteroides merdae with IBS subtypes.
- Open Access
- 28 December 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (4) , 94-99
A clinical case of post-COVID-19 myoendocarditis and arrhythmic syndrome at the outpatient stage
Background: Infection with the SARS-CoV-2 virus entails the development of complications which affect the prognosis of the underlying disease. More than 40% of COVID-19 complications represent diseases of the cardiovascular system, most of which are the rhythm and conduction disturbances. In order to avoid these complications, it is necessary to detect cases of infection in a timely manner at the outpatient stage. Clinical case description: A 40-year-old patient came to the clinic with complaints of interruptions in the heart rhythm that appeared after the coronavirus infection. The laboratory examination (CBC) revealed signs of systemic inflammation (leukocytosis 12.6×109 U/l; erythrocyte sedimentation rate 18 mm/h, C-reactive protein 18 mg/l); the instrumental examination of the heart revealed the rhythm disturbances in the form of frequent ventricular ectopic activity and weakness of the SA node. The patient received propafenone (150 mg, 3 times a day) as a therapy with a positive effect. Against the background of improvement in the patient’s condition and despite the history of myocarditis and a positive result of enzyme immunoassay for antibodies to SARS-CoV-2 (IgG, 10 BAU/ml), the patient was prescribed immunization with the CoviVac vaccine. After the immunization, the condition worsening was observed in the form of an increase in the rhythm disturbances, which required an inpatient treatment. A clinical diagnosis of recurrent ventricular arrhythmia — ventricular extrasystole was established, and the therapy was corrected. The outcome was favorable. Conclusion: Myocarditis is one of the most common complications of SARS-CoV-2 and should be kept in mind at all stages of medical care. This clinical case demonstrates the importance of the correct diagnosis and treatment of post-COVID myocarditis, as well as the need to assess contraindications for SARS-CoV-2 vaccination in patients with cardiac complications.
- 28 December 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (4) , 94-99
Open AccessA clinical case of post-COVID-19 myoendocarditis and arrhythmic syndrome at the outpatient stage
Background: Infection with the SARS-CoV-2 virus entails the development of complications which affect the prognosis of the underlying disease. More than 40% of COVID-19 complications represent diseases of the cardiovascular system, most of which are the rhythm and conduction disturbances. In order to avoid these complications, it is necessary to detect cases of infection in a timely manner at the outpatient stage. Clinical case description: A 40-year-old patient came to the clinic with complaints of interruptions in the heart rhythm that appeared after the coronavirus infection. The laboratory examination (CBC) revealed signs of systemic inflammation (leukocytosis 12.6×109 U/l; erythrocyte sedimentation rate 18 mm/h, C-reactive protein 18 mg/l); the instrumental examination of the heart revealed the rhythm disturbances in the form of frequent ventricular ectopic activity and weakness of the SA node. The patient received propafenone (150 mg, 3 times a day) as a therapy with a positive effect. Against the background of improvement in the patient’s condition and despite the history of myocarditis and a positive result of enzyme immunoassay for antibodies to SARS-CoV-2 (IgG, 10 BAU/ml), the patient was prescribed immunization with the CoviVac vaccine. After the immunization, the condition worsening was observed in the form of an increase in the rhythm disturbances, which required an inpatient treatment. A clinical diagnosis of recurrent ventricular arrhythmia — ventricular extrasystole was established, and the therapy was corrected. The outcome was favorable. Conclusion: Myocarditis is one of the most common complications of SARS-CoV-2 and should be kept in mind at all stages of medical care. This clinical case demonstrates the importance of the correct diagnosis and treatment of post-COVID myocarditis, as well as the need to assess contraindications for SARS-CoV-2 vaccination in patients with cardiac complications.
- 25 October 2023
- Published by Bionika Media in Therapy
- Vol. 7_2023
Clinical and diagnostic importance of intestinal microbiota in the development of non-specific ulcerative colitis
- 25 October 2023
- Published by Bionika Media in Therapy
- Vol. 7_2023
Clinical and diagnostic importance of intestinal microbiota in the development of non-specific ulcerative colitis
- 19 September 2023
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 14 (3) , 139-146
Features of intestinal microbiota in chronic pyelonephritis in a patient with Mayer–Rokitansky–Kustner–Hauser syndrome
MayerRokitanskyKstnerHauser syndrome is a congenital anomaly in the development of the female reproductive system, the essence of which is a violation of the intrauterine development of the Mllerian ducts, causing complete aplasia of the vagina and uterus. Deviation is a total or partial absence uterus, two upper thirds of the vagina, most often in combination with various anomalies of organs and systems, such as excretory, cardiovascular. Currently, the causes of this pathology are not fully understood studied. According to the World Health Organization, the percentage of hereditary factors intrauterine development disorders is approximately 10 to 25%. It is known that patients with this pathology often suffer from diseases of the urinary system (pyelonephritis). Chronic pyelonephritis is a common pathology in any age group due to excessive growth of the bacterial flora. The main causative agent, most often, are representatives of the intestinal microbiota (Escherichia coli, Enterococcus, Staphylococcus). Determination of the genus and species composition of the intestinal microbiota can serve as one of the diagnostic signs that contribute to the timely correction of the main therapy. Presented clinical case demonstrates a change in the biodiversity of the intestinal microbiota in a patient with MayerRokitanskyKstnerHauser syndrome, which entails timely correction of drug therapy regimens in relation to chronic pyelonephritis and achieving remission. Thus, the study of changes in the composition of the intestinal microflora can become a new criterion in the diagnosis and treatment of this disease at an early stage.
- 19 September 2023
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Pediatrician (St. Petersburg)
- Vol. 14 (3) , 139-146
Features of intestinal microbiota in chronic pyelonephritis in a patient with Mayer–Rokitansky–Kustner–Hauser syndrome
MayerRokitanskyKstnerHauser syndrome is a congenital anomaly in the development of the female reproductive system, the essence of which is a violation of the intrauterine development of the Mllerian ducts, causing complete aplasia of the vagina and uterus. Deviation is a total or partial absence uterus, two upper thirds of the vagina, most often in combination with various anomalies of organs and systems, such as excretory, cardiovascular. Currently, the causes of this pathology are not fully understood studied. According to the World Health Organization, the percentage of hereditary factors intrauterine development disorders is approximately 10 to 25%. It is known that patients with this pathology often suffer from diseases of the urinary system (pyelonephritis). Chronic pyelonephritis is a common pathology in any age group due to excessive growth of the bacterial flora. The main causative agent, most often, are representatives of the intestinal microbiota (Escherichia coli, Enterococcus, Staphylococcus). Determination of the genus and species composition of the intestinal microbiota can serve as one of the diagnostic signs that contribute to the timely correction of the main therapy. Presented clinical case demonstrates a change in the biodiversity of the intestinal microbiota in a patient with MayerRokitanskyKstnerHauser syndrome, which entails timely correction of drug therapy regimens in relation to chronic pyelonephritis and achieving remission. Thus, the study of changes in the composition of the intestinal microflora can become a new criterion in the diagnosis and treatment of this disease at an early stage.
- Open Access
- 30 June 2023
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 9 (3) , 5-11
Features of the Intestinal Microbiota in Patients with Inflammatory Intestinal Diseases
Введение. Воспалительные заболевания кишечника (ВЗК) занимают лидирующие позиции в структуре заболеваний желудочно-кишечного тракта (ЖКТ), так как являются прогрессирующей хронической патологией с аутоиммунным типом воспаления. Изменение показателей микробиоты кишечника может определять морфологические изменения на латентном этапе заболевания. Цель исследования. Оценка родо-видового биоразнообразия микробиоты у пациентов с ВЗК. Пациенты и методы. Выполнено секвенирование 16S рРНК микробиоты кишечника у 15 пациентов с подтвержденным язвенным колитом (ЯК) и 20 здоровых лиц, которые являлись контрольной группой. Проведен анализ показателей общего анализа крови и уровня С-реактивного белка (СРБ). Для статистического анализа использовали программы Microsoft Excel и Statistica. Результаты. Среди исследуемых лабораторных показателей у пациентов с ВЗК было отмечено значительное увеличение уровня СРБ, лейкоцитов и нейтрофилов по сравнению с группой контроля. В результате секвенирования кишечной микробиоты у пациентов с ВЗК выявлено снижение нормобиоты, а также увеличение содержания представителей патогенного кластера. Заключение. Выявлено снижение биоразнообразия микробиоты у пациентов с ВЗК по сравнению с группой контроля. Также наблюдалось значимое изменение патогенного кластера и дисбаланс представителей Bacteroidetes и Firmicutes. Introduction. Inflammatory bowel diseases (IBD) occupy a leading position in the structure of diseases of the gastrointestinal tract (GIT), as they are a progressive chronic pathology with an autoimmune type of inflammation. Changes in the composition of the gut microbiota can determine morphological changes at the latent stage of the disease. Aim of the study. To assess the genus-species biodiversity of the microbiota in patients with IBD. Patients and methods. 16S rRNA sequencing of the intestinal microbiota was performed in 15 patients with confirmed ulcerative colitis (UC) and 20 healthy controls. The parameters of the full blood count and the serum level of C-reactive protein (CRP) were analyzed. The analysis of the obtained data was carried out using Microsoft Excel and Statistica software. Results. Among the studied laboratory parameters in patients with IBD, there was a significant increase in CRP, leukocyte and neutrophil counts compared to the control group. Sequencing of the gut microbiota showed a decrease in the normobiota, as well as an increase in the representatives of the pathogenic cluster. Conclusion. In the present study, we demonstrated a decrease in the biodiversity of the gut microbiota in patients with IBD compared to the control group, a significant change in the pathogenic cluster, and an imbalance between the representatives of Bacteroidetes and Firmicutes.
- 30 June 2023
- Published by Scientia Publishing House LTD in Juvenis scientia
- Vol. 9 (3) , 5-11
Open AccessFeatures of the Intestinal Microbiota in Patients with Inflammatory Intestinal Diseases
Введение. Воспалительные заболевания кишечника (ВЗК) занимают лидирующие позиции в структуре заболеваний желудочно-кишечного тракта (ЖКТ), так как являются прогрессирующей хронической патологией с аутоиммунным типом воспаления. Изменение показателей микробиоты кишечника может определять морфологические изменения на латентном этапе заболевания. Цель исследования. Оценка родо-видового биоразнообразия микробиоты у пациентов с ВЗК. Пациенты и методы. Выполнено секвенирование 16S рРНК микробиоты кишечника у 15 пациентов с подтвержденным язвенным колитом (ЯК) и 20 здоровых лиц, которые являлись контрольной группой. Проведен анализ показателей общего анализа крови и уровня С-реактивного белка (СРБ). Для статистического анализа использовали программы Microsoft Excel и Statistica. Результаты. Среди исследуемых лабораторных показателей у пациентов с ВЗК было отмечено значительное увеличение уровня СРБ, лейкоцитов и нейтрофилов по сравнению с группой контроля. В результате секвенирования кишечной микробиоты у пациентов с ВЗК выявлено снижение нормобиоты, а также увеличение содержания представителей патогенного кластера. Заключение. Выявлено снижение биоразнообразия микробиоты у пациентов с ВЗК по сравнению с группой контроля. Также наблюдалось значимое изменение патогенного кластера и дисбаланс представителей Bacteroidetes и Firmicutes. Introduction. Inflammatory bowel diseases (IBD) occupy a leading position in the structure of diseases of the gastrointestinal tract (GIT), as they are a progressive chronic pathology with an autoimmune type of inflammation. Changes in the composition of the gut microbiota can determine morphological changes at the latent stage of the disease. Aim of the study. To assess the genus-species biodiversity of the microbiota in patients with IBD. Patients and methods. 16S rRNA sequencing of the intestinal microbiota was performed in 15 patients with confirmed ulcerative colitis (UC) and 20 healthy controls. The parameters of the full blood count and the serum level of C-reactive protein (CRP) were analyzed. The analysis of the obtained data was carried out using Microsoft Excel and Statistica software. Results. Among the studied laboratory parameters in patients with IBD, there was a significant increase in CRP, leukocyte and neutrophil counts compared to the control group. Sequencing of the gut microbiota showed a decrease in the normobiota, as well as an increase in the representatives of the pathogenic cluster. Conclusion. In the present study, we demonstrated a decrease in the biodiversity of the gut microbiota in patients with IBD compared to the control group, a significant change in the pathogenic cluster, and an imbalance between the representatives of Bacteroidetes and Firmicutes.
- 26 June 2023
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 16 (4) , 1240-1250
Changes in the Human Gut Microbiome Caused by the Short-Term Impact of Lactic Acid Bacteria Consumption in Healthy People
The gut microbiome is one of the main factors affecting human health. It has been proven that probiotics can regulate the metabolism in the host body. A large number of people use probiotics not as medicines, but as a prophylactic supplement. The aim of our study was to evaluate the effect of lactic acid bacteria on the gut microbiome of healthy people using the V3 region of the 16S rRNA gene. Our study showed changes in the generic composition in the gut of healthy people when taking the supplement. There was an increase in the members responsible for the production of short-chain fatty acids in the gut of the host (Blautia, Fusicatenibacter, Eubacterium hallii group, Ruminococcus), as well as bacteria that improve intestinal homeostasis (Dorea and Barnesiella). There was also a decrease in the abundance of bacteria in the genera Catenibacterium, Hungatella, Escherichia-Shigella, and Pseudomonas, associated with an unhealthy profile of the human gut microbiome. An increase in members of the phylum Actinobacteriota was also observed, which has a positive effect on the host organism. Our results indicate that short-term prophylactic use of lactic acid bacteria-based supplements can be effective, as it contributes to a beneficial effect on the gut microbiome of healthy people.
- 26 June 2023
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 16 (4) , 1240-1250
Changes in the Human Gut Microbiome Caused by the Short-Term Impact of Lactic Acid Bacteria Consumption in Healthy People
The gut microbiome is one of the main factors affecting human health. It has been proven that probiotics can regulate the metabolism in the host body. A large number of people use probiotics not as medicines, but as a prophylactic supplement. The aim of our study was to evaluate the effect of lactic acid bacteria on the gut microbiome of healthy people using the V3 region of the 16S rRNA gene. Our study showed changes in the generic composition in the gut of healthy people when taking the supplement. There was an increase in the members responsible for the production of short-chain fatty acids in the gut of the host (Blautia, Fusicatenibacter, Eubacterium hallii group, Ruminococcus), as well as bacteria that improve intestinal homeostasis (Dorea and Barnesiella). There was also a decrease in the abundance of bacteria in the genera Catenibacterium, Hungatella, Escherichia-Shigella, and Pseudomonas, associated with an unhealthy profile of the human gut microbiome. An increase in members of the phylum Actinobacteriota was also observed, which has a positive effect on the host organism. Our results indicate that short-term prophylactic use of lactic acid bacteria-based supplements can be effective, as it contributes to a beneficial effect on the gut microbiome of healthy people.
- Open Access
- 26 October 2022
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 13 (3) , 109-113
Changes in the intestinal microbiota as a predictor of the development of colorectal cancer in the elderly persons: a case study
Background: Currently, there is an increase in cancer among the elderly. Despite the obvious advances in the healthcare related to the diagnosis of the disease and its treatment, oncopathology occupies a high position in the structure of the overall morbidity. Clinical case description: Patient T., 62 years old, came to an internist with the complaints of constant pulling pains in the lower abdomen, a stool disorder in the form of alternating constipation and diarrhea, presence of blood in the stool over the past 6 months, a weight loss of 8 kg over the past 4 months. She was examined independently two years ago, when the disorders of the gastrointestinal tract appeared for the first time, which she associated with constant stressful situations at work. According to the study results, no significant deviations were found. The patient also underwent 16s-RNA sequencing of the intestinal microbiome, which revealed significant changes in many clusters of bacteria (a decrease in the quantitative composition of Lactobacterium, Bifidobacterium, Akkermansia, Faecalibacterium, which is the main representative of the normal intestinal flora, that may indicate a decrease in the protective barrier function of the colonic mucosa, an increase in Fusobacterium, as well as other representatives of the pathogenic flora). Presently, within the framework of laboratory and instrumental studies, the following diagnosis was established: "Malignant formation of the colon (colorectal cancer). T3M0N1". A repeated study of the intestinal microbiota was carried out, according to the results of which an increase in Fusobacterium up to 7.5% was observed, along with a sharp decrease in the representatives of the normoflora (1%). Conclusion: Changes in various bacterial clusters of the intestinal microbiota can serve as an early marker for the verification of malignant neoplasms of the large intestine. Determining the amount of Fusobacterium in the intestinal microbiome can be an indicator of the first diagnostic line, which helps to identify the pathological process at the stage of precancer, take timely therapeutic measures, improve the quality of life, and increase its longevity.
- 26 October 2022
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 13 (3) , 109-113
Open AccessChanges in the intestinal microbiota as a predictor of the development of colorectal cancer in the elderly persons: a case study
Background: Currently, there is an increase in cancer among the elderly. Despite the obvious advances in the healthcare related to the diagnosis of the disease and its treatment, oncopathology occupies a high position in the structure of the overall morbidity. Clinical case description: Patient T., 62 years old, came to an internist with the complaints of constant pulling pains in the lower abdomen, a stool disorder in the form of alternating constipation and diarrhea, presence of blood in the stool over the past 6 months, a weight loss of 8 kg over the past 4 months. She was examined independently two years ago, when the disorders of the gastrointestinal tract appeared for the first time, which she associated with constant stressful situations at work. According to the study results, no significant deviations were found. The patient also underwent 16s-RNA sequencing of the intestinal microbiome, which revealed significant changes in many clusters of bacteria (a decrease in the quantitative composition of Lactobacterium, Bifidobacterium, Akkermansia, Faecalibacterium, which is the main representative of the normal intestinal flora, that may indicate a decrease in the protective barrier function of the colonic mucosa, an increase in Fusobacterium, as well as other representatives of the pathogenic flora). Presently, within the framework of laboratory and instrumental studies, the following diagnosis was established: "Malignant formation of the colon (colorectal cancer). T3M0N1". A repeated study of the intestinal microbiota was carried out, according to the results of which an increase in Fusobacterium up to 7.5% was observed, along with a sharp decrease in the representatives of the normoflora (1%). Conclusion: Changes in various bacterial clusters of the intestinal microbiota can serve as an early marker for the verification of malignant neoplasms of the large intestine. Determining the amount of Fusobacterium in the intestinal microbiome can be an indicator of the first diagnostic line, which helps to identify the pathological process at the stage of precancer, take timely therapeutic measures, improve the quality of life, and increase its longevity.